Raremark, the patient data platform focused on rare disease, has partnered with the TriNetX network to bring more clinical trials to its community. TriNetX is the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE)

Actus CEO Lucinda Carney spoke on how compliance obligations can be treated as a '“tick box exercise”. Firms are missing the opportunity to view this as a change to effect cultural change.

The Cass Entrepreneurship Fund ran an event in January for its portfolio companies, co-investors and mentors from our newly launched mentor panel.

Industry experts Neil Rotherham, Tim Davis and Jeremy Edwards have been appointed Chairman, Chief Executive Officer and Chief Commercial Officer, respectively.  The new executive team now brings together over 100 years of combined experience in life sciences, particularly focused on patient engagement and mobile technology.

The Cass Entrepreneurship Fund is delighted to add iDefigo to our investment portfolio.

The iDefigo Internet of Things (“IoT”) surveillance platform is a secure cloud based solution that captures, processes and presents images, footage and information from remotely connected cameras and other devices that can be monitored using any internet-connected computer, iPhone or iPad device.

Ten thousand primary school pupils will have the opportunity to take part in free robotics workshops at Amazon’s fulfilment centres across the UK over the next two years

Cass has invested £250,000 in FibreCRM, a specialist cloud-based Client Relationship Management (CRM) system specifically for accountancy practices.  The CRM integrates the different technologies used by accountancy practices, allowing an easier flow of information and ultimately helping make accountants’ lives easier.

Actus Comply has been shortlisted for the Best FinTech Product category in the forthcoming UK Cloud Awards.

Humble Grape, the independent wine bar brand, has raised £650k for further expansion…..

Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund.….